1. Wang, Haichuan, Zhou, Yi, Xu, Hongwei, Zeng, Yong, Chen, Xin. 2022. Therapeutic efficacy of FASN inhibition in preclinical models of HCC. In Hepatology (Baltimore, Md.), 76, 951-966. doi:10.1002/hep.32359. https://pubmed.ncbi.nlm.nih.gov/35076948/
2. Dairo, Oluwademilade, DePaula Oliveira, Lia, Schaffer, Ethan, Haffner, Michael C, Lotan, Tamara L. . FASN Gene Methylation is Associated with Fatty Acid Synthase Expression and Clinical-genomic Features of Prostate Cancer. In Cancer research communications, 4, 152-163. doi:10.1158/2767-9764.CRC-23-0248. https://pubmed.ncbi.nlm.nih.gov/38112617/
3. Menendez, Javier A, Lupu, Ruth. . Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. In Nature reviews. Cancer, 7, 763-77. doi:. https://pubmed.ncbi.nlm.nih.gov/17882277/
4. Sangeetha, Manoharan, Deepa, Perinkulam Ravi, Rishi, Pukhraj, Khetan, Vikas, Krishnakumar, Subramanian. . Global gene deregulations in FASN silenced retinoblastoma cancer cells: molecular and clinico-pathological correlations. In Journal of cellular biochemistry, 116, 2676-94. doi:10.1002/jcb.25217. https://pubmed.ncbi.nlm.nih.gov/25958981/
5. Zhou, Lijie, Du, Kaixuan, Dai, Yiheng, Tian, Fengyan, Gu, Chaohui. 2024. Metabolic reprogramming based on RNA sequencing of gemcitabine-resistant cells reveals the FASN gene as a therapeutic for bladder cancer. In Journal of translational medicine, 22, 55. doi:10.1186/s12967-024-04867-8. https://pubmed.ncbi.nlm.nih.gov/38218866/
6. Ecker, Josef, Benedetti, Elisa, Kindt, Alida S D, Liebisch, Gerhard, Janssen, Klaus-Peter. 2021. The Colorectal Cancer Lipidome: Identification of a Robust Tumor-Specific Lipid Species Signature. In Gastroenterology, 161, 910-923.e19. doi:10.1053/j.gastro.2021.05.009. https://pubmed.ncbi.nlm.nih.gov/34000281/
智鼠故事 
